Literature DB >> 19898183

Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.

Yutaka Imamura1, Takamitsu Fujiwara, Ron Margolis, Richard F Spaide.   

Abstract

PURPOSE: The purpose of the study was to evaluate the choroidal thickness in patients with central serous chorioretinopathy, a disease attributed to increased choroidal vascular hyperpermeability.
METHODS: Patients with central serous chorioretinopathy underwent enhanced depth imaging spectral-domain optical coherence tomography, which was obtained by positioning a spectral-domain optical coherence tomography device close enough to the eye to acquire an inverted image. Seven sections, each comprising 100 averaged scans, were obtained within a 5 degrees x 30 degrees rectangle to encompass the macula. The subfoveal choroidal thickness was measured from the outer border of the retinal pigment epithelium to the inner scleral border.
RESULTS: The mean age of subjects undergoing enhanced depth imaging spectral-domain optical coherence tomography was 59.3 years (standard deviation, 15.8 years). Seventeen of 19 patients (89.5%) were men, and 12 (63.2%) patients had bilateral clinical disease. The choroidal thickness measured in 28 eligible eyes of the 19 patients was 505 microm (standard deviation, 124 microm), which was significantly greater than the choroidal thickness in normal eyes (P < or = 0.001).
CONCLUSION: Enhanced depth imaging spectral-domain optical coherence tomography demonstrated a very thick choroid in patients with central serous chorioretinopathy. This finding provides additional evidence that central serous chorioretinopathy may be caused by increased hydrostatic pressure in the choroid.

Entities:  

Mesh:

Year:  2009        PMID: 19898183     DOI: 10.1097/IAE.0b013e3181be0a83

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  265 in total

1.  Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome.

Authors:  Hirotaka Yokouchi; Takayuki Baba; Sonoko Misawa; Setsu Sawai; Minako Beppu; Masayasu Kitahashi; Toshiyuki Oshitari; Satoshi Kuwabara; Shuichi Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

Review 2.  Enhanced depth imaging-OCT of the choroid: a review of the current literature.

Authors:  H Laviers; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

3.  Finasteride for chronic central serous chorioretinopathy.

Authors:  Farzin Forooghian; Annal D Meleth; Catherine Cukras; Emily Y Chew; Wai T Wong; Catherine B Meyerle
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

4.  [Is choroidal thickness of importance in idiopathic macular hole?].

Authors:  K B Schaal; S Pollithy; S Dithmar
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

5.  Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography.

Authors:  Jay Chhablani; Giulio Barteselli; Haiyan Wang; Sharif El-Emam; Igor Kozak; Aubrey L Doede; Dirk-Uwe Bartsch; Lingyun Cheng; William R Freeman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

6.  Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Helena Vasconcelos; Inês Marques; A Rita Santos; Pedro Melo; Isabel Pires; João Figueira; José Faria de Abreu; M Luz Cachulo; Rufino Silva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

7.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

8.  Choriocapillaris Degeneration in Geographic Atrophy.

Authors:  Elliott H Sohn; Miles J Flamme-Wiese; S Scott Whitmore; Grefachew Workalemahu; Alexander G Marneros; Erin A Boese; Young H Kwon; Kai Wang; Michael D Abramoff; Budd A Tucker; Edwin M Stone; Robert F Mullins
Journal:  Am J Pathol       Date:  2019-04-30       Impact factor: 4.307

9.  Variation of vortex veins at the horizontal watershed in normal eyes.

Authors:  Junki Hoshino; Hidetaka Matsumoto; Ryo Mukai; Kosuke Nakamura; Yosuke Arai; Yuka Kikuchi; Shoji Kishi; Hideo Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-24       Impact factor: 3.117

10.  Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.

Authors:  Francesco Pichi; Paola Carrai; Antonio Ciardella; Francine Behar-Cohen; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2016-10-18       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.